Selected research
Industry Growth & Trends
Global Urinary and Pelvic Floor Health Solution Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Urinary and Pelvic Floor Health Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Urinary and Pelvic Floor Health Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Urinary and Pelvic Floor Health Solution is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Urinary and Pelvic Floor Health Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Urinary and Pelvic Floor Health Solution market include Peloton Health, Elvie, Renovia, InControl Medical, PeriCoach, NeoTract, NextGen Jane, Hollister Incorporated and Zimmer Biomet, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Urinary and Pelvic Floor Health Solution market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Urinary and Pelvic Floor Health Solution market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Urinary and Pelvic Floor Health Solution market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Urinary and Pelvic Floor Health Solution.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Urinary and Pelvic Floor Health Solution market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Urinary and Pelvic Floor Health Solution Market by Company
Peloton Health
Elvie
Renovia
InControl Medical
PeriCoach
NeoTract
NextGen Jane
Hollister Incorporated
Zimmer Biomet
Joylux
Medtronic
Atlantic Therapeutics
Boston Scientific
Urinary and Pelvic Floor Health Solution Segment by Type
Urology and Pelvic Floor Health Software
Urology and Pelvic Floor Health Service
Urinary and Pelvic Floor Health Solution Segment by Application
Male
Female
Urinary and Pelvic Floor Health Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urinary and Pelvic Floor Health Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Urinary and Pelvic Floor Health Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urinary and Pelvic Floor Health Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Urinary and Pelvic Floor Health Solution companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Urology and Pelvic Floor Health Software
- Urology and Pelvic Floor Health Service
Applications
- Male
- Female
Companies covered
- Peloton Health
- Elvie
- Renovia
- InControl Medical
- PeriCoach
- NeoTract
- NextGen Jane
- Hollister Incorporated
- Zimmer Biomet
- Joylux
- Medtronic
- Atlantic Therapeutics
- Boston Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Urinary and Pelvic Floor Health Solution Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Urinary and Pelvic Floor Health Solution Market Size by Region (2021-2032)
- 1.4.1 Global Urinary and Pelvic Floor Health Solution Market Size by Region (2021-2026)
- 1.4.2 Global Urinary and Pelvic Floor Health Solution Market Size by Region (2027-2032)
- 1.5 Key Regions Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 1.5.1 North America Urinary and Pelvic Floor Health Solution Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Urinary and Pelvic Floor Health Solution Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Urinary and Pelvic Floor Health Solution Market Size Growth Rate (2021-2032)
- 1.5.4 South America Urinary and Pelvic Floor Health Solution Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size Growth Rate (2021-2032)
2 Urinary and Pelvic Floor Health Solution Market by Type
- 2.1 Type Introduction
- 2.1.1 Urology and Pelvic Floor Health Software
- 2.1.2 Urology and Pelvic Floor Health Service
- 2.2 Global Urinary and Pelvic Floor Health Solution Market Size by Type
- 2.2.1 Global Urinary and Pelvic Floor Health Solution Market Size Overview by Type (2021-2032)
- 2.2.2 Global Urinary and Pelvic Floor Health Solution Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Urinary and Pelvic Floor Health Solution Market Size Forecasted by Type (2027-2032)
- 2.3 Global Urinary and Pelvic Floor Health Solution Market Size by Regions
- 2.3.1 North America Urinary and Pelvic Floor Health Solution Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Urinary and Pelvic Floor Health Solution Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Urinary and Pelvic Floor Health Solution Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Urinary and Pelvic Floor Health Solution Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Urinary and Pelvic Floor Health Solution Market Size Breakdown by Type (2021-2026)
3 Urinary and Pelvic Floor Health Solution Market by Application
- 3.1 Type Introduction
- 3.1.1 Male
- 3.1.2 Female
- 3.2 Global Urinary and Pelvic Floor Health Solution Market Size by Application
- 3.2.1 Global Urinary and Pelvic Floor Health Solution Market Size Overview by Application (2021-2032)
- 3.2.2 Global Urinary and Pelvic Floor Health Solution Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Urinary and Pelvic Floor Health Solution Market Size Forecasted by Application (2027-2032)
- 3.3 Global Urinary and Pelvic Floor Health Solution Market Size by Regions
- 3.3.1 North America Urinary and Pelvic Floor Health Solution Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Urinary and Pelvic Floor Health Solution Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Urinary and Pelvic Floor Health Solution Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Urinary and Pelvic Floor Health Solution Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Urinary and Pelvic Floor Health Solution Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Urinary and Pelvic Floor Health Solution Industry Trends
- 4.2 Urinary and Pelvic Floor Health Solution Industry Drivers
- 4.3 Urinary and Pelvic Floor Health Solution Industry Opportunities and Challenges
- 4.4 Urinary and Pelvic Floor Health Solution Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Urinary and Pelvic Floor Health Solution Revenue (2021-2026)
- 5.2 Global Urinary and Pelvic Floor Health Solution Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Urinary and Pelvic Floor Health Solution Key Company Headquarters & Area Served
- 5.4 Global Urinary and Pelvic Floor Health Solution Company, Product Type & Application
- 5.5 Global Urinary and Pelvic Floor Health Solution Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Urinary and Pelvic Floor Health Solution Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Urinary and Pelvic Floor Health Solution Players Market Share by Revenue in 2025
- 5.6.3 2025 Urinary and Pelvic Floor Health Solution Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Peloton Health
- 6.1.1 Peloton Health Company Information
- 6.1.2 Peloton Health Business Overview
- 6.1.3 Peloton Health Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Peloton Health Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.1.5 Peloton Health Recent Developments
- 6.2 Elvie
- 6.2.1 Elvie Company Information
- 6.2.2 Elvie Business Overview
- 6.2.3 Elvie Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Elvie Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.2.5 Elvie Recent Developments
- 6.3 Renovia
- 6.3.1 Renovia Company Information
- 6.3.2 Renovia Business Overview
- 6.3.3 Renovia Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Renovia Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.3.5 Renovia Recent Developments
- 6.4 InControl Medical
- 6.4.1 InControl Medical Company Information
- 6.4.2 InControl Medical Business Overview
- 6.4.3 InControl Medical Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 InControl Medical Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.4.5 InControl Medical Recent Developments
- 6.5 PeriCoach
- 6.5.1 PeriCoach Company Information
- 6.5.2 PeriCoach Business Overview
- 6.5.3 PeriCoach Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 PeriCoach Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.5.5 PeriCoach Recent Developments
- 6.6 NeoTract
- 6.6.1 NeoTract Company Information
- 6.6.2 NeoTract Business Overview
- 6.6.3 NeoTract Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 NeoTract Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.6.5 NeoTract Recent Developments
- 6.7 NextGen Jane
- 6.7.1 NextGen Jane Company Information
- 6.7.2 NextGen Jane Business Overview
- 6.7.3 NextGen Jane Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 NextGen Jane Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.7.5 NextGen Jane Recent Developments
- 6.8 Hollister Incorporated
- 6.8.1 Hollister Incorporated Company Information
- 6.8.2 Hollister Incorporated Business Overview
- 6.8.3 Hollister Incorporated Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Hollister Incorporated Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.8.5 Hollister Incorporated Recent Developments
- 6.9 Zimmer Biomet
- 6.9.1 Zimmer Biomet Company Information
- 6.9.2 Zimmer Biomet Business Overview
- 6.9.3 Zimmer Biomet Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Zimmer Biomet Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.9.5 Zimmer Biomet Recent Developments
- 6.10 Joylux
- 6.10.1 Joylux Company Information
- 6.10.2 Joylux Business Overview
- 6.10.3 Joylux Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Joylux Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.10.5 Joylux Recent Developments
- 6.11 Medtronic
- 6.11.1 Medtronic Company Information
- 6.11.2 Medtronic Business Overview
- 6.11.3 Medtronic Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Medtronic Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.11.5 Medtronic Recent Developments
- 6.12 Atlantic Therapeutics
- 6.12.1 Atlantic Therapeutics Company Information
- 6.12.2 Atlantic Therapeutics Business Overview
- 6.12.3 Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.12.5 Atlantic Therapeutics Recent Developments
- 6.13 Boston Scientific
- 6.13.1 Boston Scientific Company Information
- 6.13.2 Boston Scientific Business Overview
- 6.13.3 Boston Scientific Urinary and Pelvic Floor Health Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Boston Scientific Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.13.5 Boston Scientific Recent Developments
7 North America
- 7.1 North America Urinary and Pelvic Floor Health Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 7.3 North America Urinary and Pelvic Floor Health Solution Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Urinary and Pelvic Floor Health Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 8.3 Europe Urinary and Pelvic Floor Health Solution Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Urinary and Pelvic Floor Health Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Urinary and Pelvic Floor Health Solution Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Urinary and Pelvic Floor Health Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 10.3 South America Urinary and Pelvic Floor Health Solution Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst